Search fresh public links, source activity, and ready-to-use post angles for Regulatory Peptides.
Fresh curated links around Regulatory Peptides are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellnes...
Most of the research peptides that dominate search volume and public discussion are relatively substantial molecules — dozens of amino acids, engineered or derived from larger biol...
The FDA panel will review seven peptides and decide if they should be added to a list of substances that can be safely produced by compounding pharmacies.
An FDA committee is recommending the addition of several peptides to the 503A bulk drug substances list.The FDA’s Pharmacy Compounding Advisory Committee, which has faced scrutiny...
Por Jacqueline Howard, CNN Un grupo asesor poco conocido de la Administración de Alimentos y Medicamentos de Estados Unidos (FDA) se reunirá esta semana para evaluar si se deben fl...
Key Takeaways At its July 23-24 meeting, the FDA’s Pharmacy Compounding Advisory Committee voted narrowly in favor of adding six of seven discussed peptides to the FDA’s 503A Bulk...
A peptide is a short protein. There are countless such molecules present in the body. If used as a basis for therapy, a peptide is generally injected rather than taken orally as on...
The panel’s recommendations could shape the future of popular peptides, but some doctors say the review process itself deserves closer scrutiny.
A hastily reassembled Pharmacy Compounding Advisory Committee (PCAC) held meetings on July 23 and 24, 2026 to consider whether seven unapproved peptides should be included on an af...
Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the way for easier access.
By Karla L. Palmer & Charles D. Snow & Mary Bass —
The agency is considering whether compounding pharmacies should be allowed to produce BPC-157, TB-500 and other previously banned peptides.
Peptides are exploding in popularity. From celebrities and influencers to suburban moms and even teens, millions of people are sharing what’s in their peptide “stack” and jumping o...
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregul...
Advisers to the Food and Drug Administration are backing popular peptide therapies. They voted to allow specialized pharmacies to make them despite agency scientists' recommendatio...
WASHINGTON — An FDA advisory panel is reviewing whether compounding pharmacies should be allowed to manufacture seven specific peptides, which could make them easier to a...
MONDAY, July 27, 2026 — A federal advisory panel has recommended allowing compounding pharmacies to make two more unproven peptides while voting to reject a third.The U.S. Food an...
So-called wellness peptides are even more in the spotlight this week as the pharmacy compounding advisory committee or PCAC launches a series of meetings to evaluate restoration of...
A group of experts, some of whom work in the peptide industry, said the Food and Drug Administration should allow six peptides to be compounded, in a move that could widen access t...
The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.